source
- Personalized vaccines show promise in extending survival for some brain cancer patients, Dana-Farber study findsPersonalized cancer vaccines are being investigated as a way to make aggressive brain tumors more responsive to immunotherapy, according to new research from the Dana-Farber Cancer Institute. The…
- Revolution Medicines begins shipping experimental pancreatic cancer drug daraxonrasib under FDA early access programRevolution Medicines announced that it has started sending its experimental pancreatic cancer therapy, daraxonrasib, to doctors and patients through an FDA‑authorized early access program. The comp…STAT · 3mo agoRegulatoryPositive